CDAK
Vanguard Group’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-580,770
| Closed | -$101K | – | 4631 |
|
|
2023
Q1 | $101K | Sell |
580,770
-242,966
| -29% | -$42.4K | ﹤0.01% | 4403 |
|
|
2022
Q4 | $328K | Buy |
823,736
+379
| +0% | +$151 | ﹤0.01% | 4205 |
|
|
2022
Q3 | $644K | Buy |
823,357
+91,800
| +13% | +$71.8K | ﹤0.01% | 4150 |
|
|
2022
Q2 | $2.11M | Buy |
731,557
+115,989
| +19% | +$334K | ﹤0.01% | 3782 |
|
|
2022
Q1 | $3.86M | Sell |
615,568
-67,370
| -10% | -$422K | ﹤0.01% | 3650 |
|
|
2021
Q4 | $7.61M | Buy |
682,938
+20,080
| +3% | +$224K | ﹤0.01% | 3381 |
|
|
2021
Q3 | $10.8M | Buy |
662,858
+104,833
| +19% | +$1.71M | ﹤0.01% | 3197 |
|
|
2021
Q2 | $10.3M | Buy |
558,025
+147,614
| +36% | +$2.74M | ﹤0.01% | 3182 |
|
|
2021
Q1 | $6.19M | Buy |
410,411
+222,699
| +119% | +$3.36M | ﹤0.01% | 3415 |
|
|
2020
Q4 | $6.06M | Buy |
+187,712
| New | +$6.06M | ﹤0.01% | 3266 |
|